1. Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico (F.M.E., E.V., P.B., G.M.), Department of Clinical Sciences and Community Health, University of Milan, Endocrinology and Diabetology Unit, Milan, Italy;
2. APHP (A.L., V.G., P.H.), Reference Center for Rare Disorders of the Mineral Metabolism and Plateforme d’expertise Paris Sud Maladies Rares, Le Kremlin Bicêtre, France;
3. INSERM U1169 (A.L., V.G., P.H.), Hôpital Bicêtre, Le Kremlin Bicêtre, et Université Paris-Saclay, France;
4. Molecular (Epi)Genetics Laboratory (I.G., A.P., G.P.d.N.), BioAraba National Health Institute, Hospital Universitario Araba-Txagorritxu, Vitoria-Gasteiz, Spain;
5. Department of Public Health and Pediatrics (L.d.S., F.G.), University of Turin, Regina Margherita Children’s Hospital, Health and Science City, Turin, Italy;
6. Department of Biochemistry and Molecular Biology (A.P.), University of Basque Country, Leioa, Spain